Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is advised as a treatment option for epithelial ovarian cancer (EOC) with peritoneal carcinomatosis. This study was designed to define the pharmacokinetics of cisplatin (CDDP) and paclitaxel (PTX) administered together during HIPEC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansaloni, L, Coccolini, F, Morosi, L, Ballerini, A, Ceresoli, M, Grosso, G, Bertoli, P, Busci, L M, Lotti, M, Cambria, F, Pisano, M, Rossetti, D, Frigerio, L, D'Incalci, M, Zucchetti, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453456/
https://www.ncbi.nlm.nih.gov/pubmed/25461804
http://dx.doi.org/10.1038/bjc.2014.602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453456/
https://www.ncbi.nlm.nih.gov/pubmed/25461804
http://dx.doi.org/10.1038/bjc.2014.602

Ejemplares similares